Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc (SNOA) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.8M; returns 1 day -3.5%, 1 week -0.9%, 1 year -69.8%.

Sonoma Pharmaceuticals is a healthcare technology company focused on the development and commercialization of stabilized hypochlorous acid (HOCl) products through its proprietary Microcyn technology. The company generates revenue across three primary segments: human healthcare, animal healthcare, and contract manufacturing/service.

Groups SNOA belongs to

• Healthcare
• Pharmaceuticals
• Dermatology
• Healthcare Technology
• Over-the-Counter Drugs
• Contract Manufacturing

SNOA financial model: income statement, cash flow and balance sheet